INTRODUCTION
(continued)
On MR imaging
extremity soft-tissue sarcomas generally present as deep-seated
heterogeneous masses. They do not generally involve bone or metastasize
to lymph nodes and tend to remain compartmentalized. The adjacent
neurovascular bundle is generally displaced but not encased. In
some instances when tumor closely abuts and displaces vessels clear
adventitial resection margins may be difficult to obtain surgically.
Lobulation, hemorrhage and cystic or 'necrotic' degenerative changes
may be seen within the tumor in a non-specific fashion.
MR signal
intensity characteristics are non-specific in most instances (well
differentiated liposarcoma is an exception). However, sarcomas in
most instances, tend to exhibit signal intensity equal to or slightly
higher than adjacent skeletal muscle on T1W images. When a lesion
exhibits considerably low signal intensity relative to adjacent
skeletal muscle on T1W images, a benign lesion should be considered
in the MR differential diagnosis.
A benign
lesion may exhibit either low (fluid, fibrosis), intermediate (solid,
proteinaceous fluid) or high (hemorrhage, fat) signal intensity
relative to skeletal muscle on T1W images. Areas of cystic degeneration
or necrosis within soft-tissue sarcomas may be visualized as low
signal intensity on T1W images and foci of hemorrhage may be visualized
as high signal intensity areas on T1W images. Soft-tissue sarcomas
generally exhibit heterogenoeous high signal intensity on T2W images.
Most benign
lesions are also generally hyperintense relative to skeletal muscle
on T2W images. Rarely, soft-tissue sarcomas present as subcutaneous
or cystic masses and occasionally tumors such as myxoid liposarcoma
may present as well defined cystic masses exhibiting low signal
intensity relative to muscle on T1W images. Calcifications within
benign or malignant tumors may be visualized as low signal intensity
on T1W and T2W MR images. Neurofibrosarcomas (malignant peripheral
nerve sheath tumors) may mimic other sarcomas on MR imaging. It
should be noted that in approximately 50-60% of cases, a characteristic
target pattern may be seen in benign extracranial nerve sheath tumors
(neurofibroma or schwannoma).
|